Impulsivity in Parkinson's disease

October 30, 2017 by Allyson Mallya, Vanderbilt University

Dopamine medications are effective in treating the motor symptoms of Parkinson's disease (PD), but dopamine agonists can trigger impulsive-compulsive behaviors (ICBs), such as compulsive gambling, eating or shopping, in a subset of patients. ICBs are thought to be caused by overstimulation of the mesocorticolimbic dopamine network, which regulates reward learning and executive function.

In a collaborative effort with Manus Donahue Ph.D., Daniel Claassen, M.D., and colleagues explored the neural underpinnings of ICBs in PD using a noninvasive imaging technique called arterial-spin-labeling (ASL)-MRI. ASL-MRI quantitatively measures (CBF), an indirect measure of brain metabolism and activity.

Comparing PD patients with and without ICBs, the researchers found that dopamine agonists increase CBF in brain regions of the mesocorticolimbic network only in patients with ICBs. They also found a link between dopamine agonist-induced changes in the mesocorticolimbic network and the expression of ICBs as well as their severity across all PD patients.

This study, published in Movement Disorders, highlights the potential of using ASL-MRI to predict ICB susceptibility in patients and improve clinical treatment plans.

Explore further: Deep brain stimulation for obsessive-compulsive disorder releases dopamine in the brain

More information: Daniel O. Claassen et al. Mesocorticolimbic hemodynamic response in Parkinson's disease patients with compulsive behaviors, Movement Disorders (2017). DOI: 10.1002/mds.27047

Related Stories

Deep brain stimulation for obsessive-compulsive disorder releases dopamine in the brain

April 30, 2014
Some have characterized dopamine as the elixir of pleasure because so many rewarding stimuli - food, drugs, sex, exercise - trigger its release in the brain. However, more than a decade of research indicates that when drug ...

Intracellular dopamine receptor function may offer hope to schizophrenia patients

December 9, 2016
Dopamine is a chemical in the brain that plays an important role in controlling movement, emotion and cognition. Dopamine dysfunction is believed to be one of the causes of disorders like Schizophrenia, Tourette's syndrome, ...

Recommended for you

New evidence sheds light on how Parkinson's disease may happen

June 14, 2018
Researchers at Baylor College of Medicine and Texas Children's Hospital have identified unexpected new key players in the development of an early onset form of Parkinson's disease called Parkinsonism. These key players are ...

Scientists unravel molecular mechanisms of Parkinson's disease

June 12, 2018
Detailed brain cell analysis has helped researchers uncover new mechanisms thought to underlie Parkinson's disease.

First photoactive drug to fight Parkinson's disease

June 8, 2018
An international team has designed the first potentially therapeutic photoactive drug, MRS7145, to fight Parkinson's disease, according to the new article in Journal of Controlled Release.

Researchers address sleep problems in Parkinson's disease

June 7, 2018
A team of researchers at VIB and KU Leuven has uncovered why people with a hereditary form of Parkinson's disease suffer from sleep disturbances. The molecular mechanisms uncovered in fruit flies and human stem cells also ...

Drugs that suppress immune system may protect against Parkinson's

May 31, 2018
People who take drugs that suppress the immune system are less likely to develop Parkinson's disease, according to a study from Washington University School of Medicine in St. Louis.

Early synaptic dysfunction found in Parkinson's Disease

May 24, 2018
Northwestern Medicine scientists identified a cellular mechanism that leads to neurodegeneration in patients with Parkinson's disease, according to a study published in Proceedings of the National Academy of Sciences.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.